Summary

Overview
Global Wound Irrigation System Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Wound irrigation is a crucial intervention in wound care that reduces infection risk by removing foreign material, reducing bacterial contamination, and removing cellular debris or exudate. It should be vigorous enough to achieve these goals but gentle enough to prevent further tissue trauma or passage of bacteria. Proper personal protective equipment is essential for wound care providers performing wound irrigation, as body fluids may splash or spray due to pressure.
Market Dynamics: Drivers & Restraints
Rise in the number of surgical procedures
The goal of wound irrigation is to remove foreign material, decrease bacterial contamination of the wound, and remove cellular debris or exudate from the surface of the wound. The rise in surgical procedures indeed helped the market to grow during the forecast period.
For instance, the Lancet Commission on Global Surgery (LCoGS) states a minimum of 5000 surgical procedures per 100,000 persons, and a specialist surgical workforce density of 20 per 100,000 persons are needed to improve access to surgical care in each country.

Challenges associated with wound irrigation system

The wound irrigation systems market faces several challenges, including the high cost of advanced systems, limited accessibility in developing regions, variable reimbursement policies, infection control concerns, and a preference for manual systems. Advanced systems are expensive and sophisticated, making them difficult to adopt in these regions. Access to advanced systems may be limited due to infrastructure gaps, inadequate healthcare facilities, and economic constraints.
For more details on this report – Request for Sample
Segment Analysis
The global wound irrigation system market is segmented based on product type, application, end-user, and region.
The manual wound irrigation system from the product type segment accounted for approximately 54.3% of the wound irrigation system market share
The manual wound irrigation system from the product type segment accounted for approximately 54.3%. The manual wound irrigation system uses thumb-controlled pressure to clean hard-to-heal or deep surgical wounds. It is expected to grow due to high incidences of diabetic foot ulcers and surgical site infections in low-income countries, accelerating the segment's growth. The manual wound irrigation system is more convenient because it contains a pressure control button, which provides an accurate forceful stream of solution directly to the desired site.
Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like product launches, increase in incidence of chronic diseases such as diabetes, presence of key players, surge in incidence rate of surgical site infections & diabetic foot ulcers, and rise in demand for early diagnosis.
For instance, in May 2021, BD (Becton, Dickinson and Company) announced the availability of BD Surgiphor Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris. BD Surgiphor is a pre-mixed, pre-labeled, single-patient surgical wound irrigation solution.
Market Segmentation
By Product Type
• Manual
o Syringe
o Spray
o Nozzle
• Battery-operated
By Application
• Chronic Wounds
• Surgical Wounds
• Others
By End-User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include CooperSurgical Inc., Zimmer Biomet, Stryker Corporation, Becton, Dickinson and Company, Medline Industries, Inc., BIONIX LLC, Irrimax Corporation, Essity Health & Medical, Cardinal Health, and Henry Schein among others.
Key Developments
• For instance, in November 2022, InfuSystem Holdings, Inc. and Sanara MedTech Inc. formed an SI wound Care partnership that focuses on providing wound care systems to improve patient outcomes. This strategic initiative is expected to reduce the cost of care, improve outcomes, and strengthen the position of these companies in the market.
Why Purchase the Report?
• To visualize the global wound irrigation system market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the wound irrigation system market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global wound irrigation system market report would provide approximately 64 tables, 61 figures, and 186 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the number of surgical procedures
4.1.1.2. Rise in technological advancements
4.1.2. Restraints
4.1.2.1. Challenges associated with wound irrigation system
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Manual*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Battery operated
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Chronic Wounds*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Surgical Wounds
7.4. Others
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Ambulatory Surgical Centers
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. CooperSurgical Inc*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.2. Zimmer Biomet
11.3. Stryker Corporation
11.4. Becton, Dickinson and Company
11.5. Medline Industries, Inc
11.6. BIONIX LLC
11.7. Irrimax Corporation
11.8. Essity Health & Medical
11.9. Cardinal Health
11.10. Henry Schein
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us